This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Century Therapeutics has joined the onslaught of cell therapy biotechs taking hi...
Health tech company Flatiron Health, an independent affiliate of the Roche Group...
Cell therapy biotech bit.bio is slimming its workforce down by 25% as the compan...
Dexcom found that just over half of healthcare providers ranked technology and e...
As fungi resistant to traditional treatments continue to spread around the globe...
The brain-computer interface developer Synchron has laid out plans to build an A...
The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 mil...
A phase 3 trial of Immunovant’s FcRn inhibitor batoclimab has hit its primary en...
As always, if you know of layoffs occurring at a biotech, please reach out to th...
A phase 3 trial of Immunovant’s FcRn inhibitor batoclimab has hit its primary en...
Black Diamond Therapeutics has found a partner for its deprioritized solid tumor...
Greenlighted for people ages 6 and older with Type 1 diabetes, Sequel’s twiist s...
Roche has secured its third antibody-drug conjugate deal of the year, this time ...
Just a few months after dumping its lead asset and cutting its workforce in half...
After serving as the director of the National Human Genome Research Institute fo...
Empress Therapeutics is halving its team, letting go of 23 employees as the biot...
That includes generative AI applications that could “connect employees and custo...
As always, if you know of layoffs occurring at a biotech, please reach out to th...
Empress Therapeutics is halving its team, letting go of 23 employees as the biot...
Greenlit for people ages six and older with Type 1 diabetes, Sequel’s twiist sys...
As always, if you know of layoffs occurring at a biotech, please reach out to th...
The Cambridge, Massachusetts-based biotech is closing “following careful conside...
Vincerx Pharma has found a fast fix for the uncertainty over its future. Recentl...
The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 mil...